Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Philip Bourne and Ruth Nussinov


Philip Bourne has stepped down from his position as editor in chief of PLOS Computational Biology, a role he has held for seven years.

Bourne, who was also one of the founders of PLOS Computational Biology, said in an editorial that he will still be involved with the journal — he will focus on special projects.

Bourne is a professor with the Skaggs School of Pharmacy and Pharmaceutical Sciences at the University of California San Diego. He is also associate director of the RCSB Protein Data Bank and an adjunct professor at the Sanford Burnham Institute.

Ruth Nussinov, who has served as the journal’s deputy editor in chief since October 2008, will take over Bourne’s responsibilities at the journal.

She is a professor in the department of human genetics at Tel Aviv University’s School of Medicine and a senior principal scientist and principal investigator at the National Cancer Institute.

She got her bachelors degree in microbiology from the University of Washington and obtained her doctorate in biochemistry from Rutgers University.

Filed under

The Scan

Follow-Up Data Requests to Biobank Participants Ineffective, Study Finds

An effort to recontact biobank enrollees for additional information reports low participation in a new BMJ Open study.

Study Finds Widespread Transmission of Resistant Bacteria in Vietnam Hospitals

A sequencing study in The Lancet Microbe finds widespread transmission of drug-resistant Escherichia coli, Klebsiella pneumoniae, and Acinetobacter baumannii in two Vietnam ICUs.

Novel Brain Cell Organoids Show Promise for Autism Research

University of Utah researchers report in Nature Communications on their development of brain cell organoids to study SHANK3-related autism.

Study Finds Few FDA Post-Market Regulatory Actions Backed by Research, Public Assessments

A Yale University-led team examines in The BMJ safety signals from the US FDA Adverse Event Reporting System and whether they led to regulatory action.